News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No market-moving headlines were published in the past hour.
  • No central bank statements or policy actions were issued in the past hour.
  • No significant economic data releases occurred in the past hour.
  • No notable corporate earnings, guidance updates, or M&A announcements were reported.
  • No fresh geopolitical incidents or sanctions were reported in the past hour.
  • Light news flow leaves markets without new headline-driven catalysts for now.

Latest Articles

Zoetis Shares Drop After Q2 Results and Reduced Full-Year Outlook

Zoetis Shares Drop After Q2 Results and Reduced Full-Year Outlook

Zoetis shares fell in pre-market trading after the company reported second-quarter 2026 results that narrowly beat EPS estimates but missed revenue expectations and issued full-year EPS guidance well below analyst consensus. Management also announced a combined CFO and COO appointment, contributing to investor unease as the stock approaches multi-y…

D-Wave Reports Q2 Shortfall on Revenue and EPS, Stock Drops in Pre-Market

D-Wave Reports Q2 Shortfall on Revenue and EPS, Stock Drops in Pre-Market

D-Wave Quantum Inc. reported second-quarter results that missed analyst expectations on both revenue and earnings per share, prompting a 10.5% decline in pre-market trading. Revenue for the quarter was $3.07 million versus consensus of $4.03 million, and EPS came in at ($0.13), short of the ($0.09) estimate. The company posted a narrower net loss y…

Howmet Aerospace Stock Jumps After Strong Q2 Results and Raised Guidance

Howmet Aerospace Stock Jumps After Strong Q2 Results and Raised Guidance

Howmet Aerospace rallied in pre-market trading after posting second-quarter 2026 results that exceeded analyst estimates across key metrics and prompted management to raise full-year guidance. The company reported Q2 EPS of $1.33 on $2.55 billion in revenue, delivered robust margin expansion and free cash flow, and now expects higher full-year earn…

Papa John’s Shares Fall After Modest Q2 Beat and Leadership Changes

Papa John’s Shares Fall After Modest Q2 Beat and Leadership Changes

Papa John’s stock fell sharply in pre-market trading after the pizza chain reported second-quarter 2026 results that narrowly exceeded analyst expectations on both earnings and revenue but still showed a meaningful year-over-year sales decline. The company also announced immediate leadership changes and continues to operate without a permanent chie…

Datadog Shares Plunge Pre-Market Despite Beat-and-Raise Quarter

Datadog Shares Plunge Pre-Market Despite Beat-and-Raise Quarter

Datadog shares fell sharply in pre-market trading after the company reported stronger-than-expected second-quarter results and lifted full-year guidance. The drop, driven largely by profit-taking following a substantial pre-earnings rally, came even though Datadog topped consensus on both revenue and earnings per share.

Unity Shares Rally After Strong Q2 Results and Upbeat Q3 Guidance

Unity Shares Rally After Strong Q2 Results and Upbeat Q3 Guidance

Unity Software's stock jumped 17% after the company reported a stronger-than-expected second quarter, with revenue and adjusted-profit metrics beating analyst estimates and management issuing a bullish revenue and adjusted EBITDA outlook for the third quarter. Strategic revenue, excluding certain business lines, showed particularly strong growth, w…

Constellation Energy Jumps After Q2 Results and Board Changes

Constellation Energy Jumps After Q2 Results and Board Changes

Constellation Energy Corp. stock surged 4.4% in pre-open trading after the company posted a second-quarter adjusted operating earnings beat and raised its fiscal 2026 outlook. Management also announced two board-level moves in the days ahead of the earnings release, reinforcing investor confidence despite recent analyst target cuts.

Insmed Shares Leap After Q2 Results and Bullish Brinsupri Guidance

Insmed Shares Leap After Q2 Results and Bullish Brinsupri Guidance

Insmed shares jumped 19.2% in pre-market trading after the company reported second-quarter 2026 results that outpaced analyst expectations on both revenue and EPS. Total revenue reached $425.5 million, led by Brinsupri sales of $309.2 million, and the company posted a near-breakeven net loss of $0.06 per share. Management raised full-year Brinsupri…

Fiserv Shares Plummet After Q2 Results Miss and Guidance Cut

Fiserv Shares Plummet After Q2 Results Miss and Guidance Cut

Fiserv's stock tumbled sharply in pre-market trading after the payments processor reported second-quarter results that missed expectations and issued weaker full-year guidance. Adjusted revenue and EPS declined year-over-year, management trimmed organic revenue and adjusted EPS forecasts for 2026, and investor concern has been amplified by recent l…

BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease

BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease

BioVie Inc. announced positive topline results from its Phase 2 SUNRISE-PD trial evaluating bezisterim in early-stage Parkinson's disease patients. The drug met its primary and secondary endpoints, showing significant improvements on motor and non-motor symptoms, beneficial effects on neuroinflammation biomarkers, and a broadly favorable proteomic …

Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

Abeona Therapeutics Inc. will hold a conference call on August 13, 2026, to discuss its second quarter financial results and provide a corporate update. The company is a commercial-stage biopharmaceutical firm focused on developing cell and gene therapies for serious diseases, including its FDA-approved ZEVASKYN therapy for recessive dystrophic epi…

Parker Reports Record Fiscal 2026 Fourth Quarter and Full Year Results

Parker Reports Record Fiscal 2026 Fourth Quarter and Full Year Results

Parker Hannifin Corporation announced record financial results for the fiscal 2026 fourth quarter and full year, with significant increases in sales, net income, and earnings per share. The company delivered operational excellence marked by improved segment operating margins and strong organic sales growth across all segments. Strategic acquisition…

MACOM Reports Fiscal Third Quarter 2026 Financial Results

MACOM Reports Fiscal Third Quarter 2026 Financial Results

MACOM Technology Solutions Holdings, Inc. announced robust financial results for its fiscal third quarter ended July 3, 2026, reporting a 35.8% year-over-year increase in revenue to $342.2 million and a significant rise in net income to $100.7 million ($1.28 per diluted share), driven by strong demand in telecommunications, industrial, defense, and…

Genie Energy Announces Second Quarter 2026 Results

Genie Energy Announces Second Quarter 2026 Results

Genie Energy Ltd. announced its second quarter 2026 financial results, highlighting a decrease in revenue but strong growth in gross profit, income from operations, net income, and earnings per share. The company experienced improved gross margins driven by normalized wholesale energy market conditions and focused customer acquisition in high-value…